Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer

被引:32
作者
Jones, M. R. [1 ]
Schrader, K. A. [2 ]
Shen, Y. [1 ]
Pleasance, E. [1 ]
Ch'ng, C. [1 ]
Dar, N. [1 ]
Yip, S. [3 ]
Renouf, D. J. [4 ]
Schein, J. E. [1 ]
Mungall, A. J. [1 ]
Zhao, Y. [1 ]
Moore, R. [1 ]
Ma, Y. [1 ]
Sheffield, B. S. [3 ]
Ng, T. [3 ]
Jones, S. J. M. [1 ,2 ,5 ]
Marra, M. A. [1 ,2 ]
Laskin, J. [4 ]
Lim, H. J. [4 ]
机构
[1] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, 600 West 10th Ave, Vancouver, BC V5Z 4E6, Canada
[2] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
[3] Vancouver Gen Hosp, Dept Pathol & Lab Med, Vancouver, BC, Canada
[4] British Columbia Canc Agcy, Div Med Oncol, 600 West 10th Ave, Vancouver, BC V5Z 4E6, Canada
[5] Simon Fraser Univ, Dept Mol Biol & Biochem, Vancouver, BC, Canada
关键词
personalized medicine; AP-1; complex; irbesartan; chemo-refractory colon cancer; RNA expression analysis; mismatch repair defective; GROWTH-FACTOR-BETA; FAMILY-MEMBERS; COLON-CANCER; CELLS; JUN; EXPRESSION; THERAPY; INHIBITION; SURVIVAL; AP-1;
D O I
10.1093/annonc/mdw060
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Personalised oncogenomics analysis revealed potential oncogene addiction of the AP-1 transcriptional complex in a chemo-refractory and MMR-deficient tumor from a patient with metastatic colon cancer. Based on this, treatment with the angiotensin receptor agonist irbesartan was initiated to target the renin-angiotensin system upstream of the AP-1 complex, leading to a profound and durable response.A patient suffering from metastatic colorectal cancer, treatment-related toxicity and resistance to standard chemotherapy and radiation was assessed as part of a personalized oncogenomics initiative to derive potential alternative therapeutic strategies. Whole-genome and transcriptome sequencing was used to interrogate a metastatic tumor refractory to standard treatments of a patient with mismatch repair-deficient metastatic colorectal cancer. Integrative genomic analysis indicated overexpression of the AP-1 transcriptional complex suggesting experimental therapeutic rationales, including blockade of the renin-angiotensin system. This led to the repurposing of the angiotensin II receptor antagonist, irbesartan, as an anticancer therapy, resulting in the patient experiencing a dramatic and durable response. This case highlights the utility of comprehensive integrative genomic profiling and bioinformatics analysis to provide hypothetical rationales for personalized treatment options.
引用
收藏
页码:801 / 806
页数:6
相关论文
共 27 条
[1]   AP-1 and colorectal cancer [J].
Ashida R. ;
Tominaga K. ;
Sasaki E. ;
Watanabe T. ;
Fujiwara Y. ;
Oshitani N. ;
Higuchi K. ;
Mitsuyama S. ;
Iwao H. ;
Arakawa T. .
InflammoPharmacology, 2005, 13 (1-3) :113-125
[2]   Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy [J].
Campistol, JM ;
Iñigo, P ;
Jimenez, W ;
Lario, S ;
Clesca, PH ;
Oppenheimer, F ;
Rivera, F .
KIDNEY INTERNATIONAL, 1999, 56 (02) :714-719
[3]   Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1 [J].
Cheng, SM ;
Yang, SP ;
Ho, LJ ;
Tsao, TP ;
Chang, DM ;
Lai, JH .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (06) :933-942
[4]   Complexities of TGF-β Targeted Cancer Therapy [J].
Connolly, Erin C. ;
Freimuth, Julia ;
Akhurst, Rosemary J. .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2012, 8 (07) :964-978
[5]   Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer [J].
Engineer, Diana R. ;
Burney, Basil O. ;
Hayes, Teresa G. ;
Garcia, Jose M. .
TRANSLATIONAL ONCOLOGY, 2013, 6 (05) :539-545
[6]   Transcriptional regulation in the immune system: all roads lead to AP-1 [J].
Foletta, VC ;
Segal, DH ;
Cohen, DR .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (02) :139-152
[7]   AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma [J].
Kappelmann, Melanie ;
Bosserhoff, Anja ;
Kuphal, Silke .
EUROPEAN JOURNAL OF CELL BIOLOGY, 2014, 93 (1-2) :76-81
[8]   Smad2 and Smad3 Inversely Regulate TGF-β Autoinduction in Clostridium butyricum-Activated Dendritic Cells [J].
Kashiwagi, Ikkou ;
Morita, Rimpei ;
Schichita, Takashi ;
Komai, Kyoko ;
Saeki, Keita ;
Matsumoto, Makoto ;
Takeda, Kiyoshi ;
Nomura, Masatoshi ;
Hayashi, Atsushi ;
Kanai, Takanori ;
Yoshimura, Akihiko .
IMMUNITY, 2015, 43 (01) :65-79
[9]   The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes [J].
Kim, Tae-Min ;
Laird, Peter W. ;
Park, Peter J. .
CELL, 2013, 155 (04) :858-868
[10]   Multiple roles of angiotensin in colorectal cancer [J].
Kuniyasu, Hiroki .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2012, 3 (12) :150-154